Shuangshuang
Duan
a,
Dan
Long
a,
Changgui
Zhao
a,
Gaoyuan
Zhao
a,
Ziyun
Yuan
a,
Xingang
Xie
a,
Jianguo
Fang
a and
Xuegong
She
*ab
aState Key Laboratory of Applied Organic Chemistry, Department of Chemistry, Lanzhou University, Lanzhou, 730000, China. E-mail: shexg@lzu.edu.cn
bCollaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin, 30071, China
First published on 18th July 2016
An efficient approach for the synthesis of the 9/6/6 tricyclic structure of Lycopodium alkaloid palhinine A has been accomplished. The developed synthetic route features oxidative dearomatization and tandem hydroxyl oxidation/intramolecular Diels–Alder (IMDA) reactions to assemble the A/C/D tricyclic ring system. Most importantly, the protocol can undergo ring constriction to rapidly construct the highly strained nine-membered azonane ring of palhinine A.
Given their biological activity and intriguing molecular architecture, the synthesis of palhinines has been widely explored.3 Our group accomplished the 6/6/5 tricyclic ring system by a tandem oxidative dearomatization/intramolecular Diels–Alder reaction4,5 and an intramolecular radical cyclization. At the same time, Fan and co-workers developed a concise strategy to build the isotwistane core3b,6 using the Nozaki–Hiyama–Kishi/IMDA reaction. The Maier group described their approach for constructing the isotwistane core by employing a domino Michael/Arndt–Eistert homologation/intramolecular aldol sequence. Rychnovsky and co-workers utilized a Morita–Baylis–Hillman/IMDA strategy to complete the isotwistane core as well.
Unfortunately, all the elegant previous studies were incomplete with respect to the total syntheses of palhinines with the deficiency of the nine-membered azonane ring. After the construction of the isotwistane core, we have made many attempts to achieve the A ring, but none of them gave the desired result, which made the nine-membered azonane ring the most challenging problem. Although a series of studies on the establishment of the medium-sized ring have been reported,7–11 the much more strained nine-membered azonane ring fused with the caged structure of bicycle[2.2.2]octanone has not been accomplished. As a continuation of our previous work,3a we wish to describe the synthesis of the A/C/D tricyclic core of palhinine A (1) through ring constriction from a macro-sized ring in order to overcome the strain of the nine-membered azonane ring.12
On the basis of the above analysis, our synthesis commenced with the known ester 8
3a (Scheme 2). Reduction of ester 8 with LiAlH4 followed by treatment of the resulting alcohol with mesyl chloride resulted in the formation of the corresponding mesylate 9 in 90% yield over two steps.
Conversion of mesylate 9 to sulfonamide 10 was achieved through a three-step sequence involving azide generation, amine formation and sulfonylation in 78% yield. Then sulfonamide 10 was reacted with propylene glycol derivative 11
13 to afford 12,14 which was subjected to deprotection to provide alcohol 13 in 90% yield. The Swern oxidation of 13 proceeded smoothly to afford aldehyde 7 in excellent yield. During the period of synthesis of the dienophile fragment of 6, various reaction conditions were screened.3d,15 Among them, the optimized condition was that the reaction should be performed under an atmosphere of Ar with methyl acrylate being used as a solvent and DABCO as a base to provide 6 in 52% yield.
Next, as shown in Scheme 3, we investigated the synthesis of key intermediate 17. Protection of the secondary hydroxyl group of dienophile 6 followed by reduction of the ester group gave the corresponding primary alcohol 15.16 Exposure of 15 to 2 M HCl resulted in diol 16 in 86% yield. When diol 16 was treated with PhI(OCOCF3)2 under open air at 0 °C, an unexpected ortho-quinone was delivered as a major product with a small amount of 17. After many trials, the reaction was found to proceed smoothly to afford 17 as a mixture of diastereoisomers with a solution of PhI(OCOCF3)2 in CH2Cl2 being added dropwise at 0 °C under an inert atmosphere, and the yield could be increased to 60%.
As illustrated in Scheme 4, with 17 in hand, the stage was set for the development of the A/C/D tricyclic skeleton of palhinine A (1). Our initial attempt to apply 17 in refluxed toluene to promote the cyclization failed to give any desired products. In addition, Et2AlCl was also ineffective under typical reaction conditions. We postulated that the failure was attributed to the low reactivity of the substrate. To overcome this obstacle, the hydroxyl group was oxidized to convert the dienophile into the corresponding unsaturated ketone. Fortunately, when the hydroxyl group was oxidized with DMP (Dess–Martin periodinane) at 0 °C, the resulting enone was converted to 5 spontaneously in 42% yield, the structure of which was further confirmed by single-crystal X-ray diffraction analysis.17
:
1) to give the alcohol 9a (3.21 g, 14.2 mmol, 98% yield) as a colorless oil. IR νmax (neat)/cm−1: 3403, 2935, 2372, 1585, 1477, 1431, 1265, 1221, 1204, 1154, 1120; 1H NMR (400 MHz, CDCl3): δ 6.98 (m, 2H), 6.84 (dd, J = 7.2, 1.6 Hz, 1H), 5.22 (s, 2H), 3.86 (s, 3H), 3.59 (t, J = 5.6 Hz, 2H), 3.52 (s, 3H), 2.74 (t, J = 7.2 Hz, 2H), 2.22 (br, 1H), 1.84 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 150.08, 147.83, 135.55, 124.13, 123.38, 114.44, 95.04, 61.51, 60.84, 56.15, 33.41, 25.63; HRMS (ESIMS) calcd for C12H18O8Na1 [M + Na]+ 249.1097, found 249.1093.
:
1) to give 9 (3.98 g, 13.1 mmol, 92% yield) as a colourless oil. IR νmax (neat)/cm−1: 3399, 2938, 1601, 1585, 1478, 1354, 1267, 1222, 1175, 1087, 1006, 923; 1H NMR (400 MHz, CDCl3): δ 7.03 (dd, J = 8.0, 1.2 Hz, 1H), 6.97 (t, J = 8.0 Hz, 1H), 6.83 (d, J = 8.0 Hz, 1H), 5.22 (s, 2H), 4.24 (t, J = 6.4 Hz, 2H), 3.85 (s, 3H), 3.52 (s, 3H), 3.00 (s, 3H), 2.76 (t, J = 7.2 Hz, 2H), 2.06 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 150.31, 147.91, 134.37, 124.00, 123.27, 114.87, 95.02, 69.57, 60.70, 56.19, 37.27, 29.82, 26.03; HRMS (ESIMS) calcd for C13H20O6S1Na1 [M + Na]+ 327.0873, found 327.0865.
:
1) to give the azide 10a (2.76 g, 11.0 mmol, 84% yield) as a colourless oil. IR νmax (neat)/cm−1: 3341, 2935, 2097, 1585, 1478, 1267, 1154, 1088, 1015, 925; 1H NMR (400 MHz, CDCl3): δ 7.02 (dd, J = 8.0, 1.6 Hz, 1H), 6.96 (t, J = 8.0 Hz, 1H), 6.82 (dd, J = 7.4, 1.6 Hz, 1H), 5.21 (s, 2H), 3.86 (s, 3H), 3.51 (s, 3H), 3.30 (t, J = 6.8 Hz, 2H), 2.71 (t, J = 7.2 Hz, 2H), 1.89 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 150.27, 147.89, 134.92, 123.87, 123.23, 114.69, 95.00, 60.63, 56.11, 50.81, 29.59, 27.11; HRMS (ESIMS) calcd for C12H17N3O3Na1 [M + Na]+ 274.1162, found 274.1158.
The amine obtained, p-TsCl (2.26 g, 11.9 mmol) and Et3N (4.3 mL, 30 mmol) were dissolved in CH2Cl2 (100 mL) and stirred at 25 °C for 8 h. The reaction mixture was taken up in CH2Cl2 and washed successively with 1 M NaOH (2 × 20 mL), H2O (30 mL) and brine (30 mL). The organic layer was dried over anhydrous Na2SO4, filtered and concentrated. The residue was purified through silica gel column chromatography (n-hexane/EtOAc, 4
:
1) to give 10 (3.49 g, 9.21 mmol, 93% yield) as a clear crystal. M.p. 94–96 °C; IR νmax (neat)/cm−1: 3282, 2933, 1599, 1585, 1477, 1326, 1266, 1158, 1093, 1021; 1H NMR (400 MHz, CDCl3): δ 7.74 (d, J = 8.0 Hz, 2H), 7.27 (d, J = 8.0 Hz, 2H), 6.98 (dd, J = 8.4, 1.6 Hz, 1H), 6.91 (t, J = 7.6 Hz, 1H), 5.19 (s, 2H), 5.11 (t, J = 6.0 Hz, 1H), 3.82 (s, 3H), 3.50 (s, 3H), 2.89 (q, J = 6.4 Hz, 2H), 2.62 (t, J = 4.8 Hz, 2H), 2.40 (s, 3H), 1.75 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 150.09, 147.67, 143.08, 137.04, 134.73, 129.54, 126.98, 124.06, 123.21, 114.57, 94.98, 60.78, 56.13, 42.19, 30.33, 26.36, 21.40; HRMS (ESIMS) calcd for C19H25N1O5S1Na1 [M + Na]+ 402.1346, found 402.1339.
:
1) to give 12 (2.85 g, 5.17 mmol, 80% yield) as a colourless oil. IR νmax (neat)/cm−1: 3368, 2954, 2929, 2857, 1599, 1586, 1475, 1342, 1260, 1158, 1090, 1011; 1H NMR (400 MHz, CDCl3): δ 7.81 (d, J = 8.4 Hz, 2H), 7.41 (d, J = 8.0 Hz, 2H), 7.15–7.06 (m, 2H), 6.93 (d, J = 7.6 Hz, 1H), 5.34 (s, 2H), 3.95 (s, 3H), 3.72 (t, J = 6.0 Hz, 2H), 3.65 (s, 3H), 3.33 (q, J = 7.2 Hz, 4H), 2.74 (t, J = 8.0 Hz, 2H), 2.54 (s, 3H), 2.00–1.92 (m, 2H), 1.90–1.83 (m, 2H), 1.00 (s, 9H), 0.15 (s, 6H); 13C NMR (100 MHz, CDCl3): δ 150.25, 147.86, 142.92, 136.85, 135.45, 129.55, 127.16, 123.90, 123.14, 114.58, 95.08, 60.70, 60.37, 56.18, 48.35, 45.36, 31.95, 29.39, 27.22, 25.85, 21.45, 18.19, −5.43, −5.47; HRMS (ESIMS) calcd for C28H45N1O6S1Si1Na1 [M + Na]+ 574.2629, found 574.2634.
:
1) to give the alcohol 13 (1.86 g, 4.26 mmol, 90% yield) as a colourless oil. IR νmax (neat)/cm−1: 3531, 2936, 1736, 1599, 1585, 1477, 1336, 1268, 1157, 1018; 1H NMR (400 MHz, CDCl3): δ 7.67 (d, J = 8.0 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 7.00 (dd, J = 8.0, 1.6 Hz, 1H), 6.95 (t, J = 8.0 Hz, 1H), 6.78 (dd, J = 7.6, 1.6 Hz, 1H), 5.21 (s, 2H), 3.81 (s, 3H), 3.74 (q, J = 6.0 Hz, 2H), 3.51 (s, 3H), 3.23 (t, J = 6.4 Hz, 2H), 3.18 (t, J = 7.6 Hz, 2H), 2.61–2.55 (m, 3H), 2.41 (s, 3H), 1.85–1.80 (m, 2H), 1.78–1.71 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 150.18, 147.73, 143.19, 136.24, 135.18, 129.63, 127.01, 123.92, 123.09, 114.61, 94.99, 60.65, 58.73, 56.14, 48.90, 44.97, 31.39, 29.58, 27.30, 21.40; HRMS (ESIMS) calcd for C22H31N1O6S1Na1 [M + Na]+ 460.1764, found 460.1761.
:
1) to give 7 (1.81 g, 4.16 mmol, 98% yield) as a colourless oil. IR νmax (neat)/cm−1: 3425, 2934, 1723, 1598, 1585, 1478, 1339, 1268, 1158, 1090, 1012, 920; 1H NMR (400 MHz, CDCl3): δ 9.74 (s, 1H), 7.67 (d, J = 8.0 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 7.01 (dd, J = 8.0, 1.6 Hz, 1H), 6.95 (t, J = 8.0 Hz, 1H), 6.79 (dd, J = 7.2, 1.6 Hz, 1H), 5.21 (s, 2H), 3.83 (s, 3H), 3.51 (s, 3H), 3.41 (t, J = 7.2 Hz, 2H), 3.17 (t, J = 7.2 Hz, 2H), 2.82 (t, J = 7.2 Hz, 2H), 2.61 (t, J = 7.6 Hz, 2H), 2.42 (s, 3H), 1.83–1.75 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 200.16, 150.20, 147.77, 143.35, 136.01, 135.10, 129.68, 127.10, 123.90, 123.10, 114.65, 95.01, 60.63, 56.13, 49.02, 43.94, 41.73, 29.38, 27.21, 21.40; HRMS (ESIMS) calcd for C22H29N1O6S1Na1 [M + Na]+ 458.1608, found 458.1614.
:
1) to give 6 (1.14 g, 2.19 mmol, 52% yield) as a colourless oil. IR νmax (neat)/cm−1: 3509, 3297, 2952, 2936, 1721, 1478, 1440, 1336, 1267, 1157, 1090, 1018, 926; 1H NMR (400 MHz, CDCl3): δ 7.67 (d, J = 8.0 Hz, 2H), 7.28 (d, J = 8.0 Hz, 2H), 7.00 (dd, J = 8.0, 1.6 Hz, 1H), 6.94 (t, J = 8.0 Hz, 1H), 6.80 (dd, J = 7.6, 1.6 Hz, 1H), 6.26 (s, 1H), 5.90 (s, 1H), 5.20 (s, 2H), 4.58 (t, J = 4 Hz, 1H), 3.81 (s, 3H), 3.74 (s, 3H), 3.51 (s, 3H), 3.48–3.41 (m, 1H), 3.30–3.20 (m, 1H), 3.19–3.07 (m, 3H), 2.60 (t, J = 8.0 Hz, 2H), 2.41 (s, 3H), 2.05–1.97 (m, 1H), 1.89–1.79 (m, 2H), 1.72–1.63 (m, 1H); 13C NMR (100 MHz, CDCl3): δ 166.64, 150.22, 147.85, 143.17, 142.01, 136.42, 135.28, 129.64, 127.12, 125.16, 123.90, 123.16, 114.68, 95.09, 67.76, 60.68, 56.17, 51.80, 48.67, 45.10, 35.35, 29.36, 27.24, 21.44; HRMS (ESIMS) calcd for C26H36N1O8S1 [M + H]+ 522.2156, found 522.2166.
:
1) to give 14 (2.97 g, 4.68 mmol, 86% yield) as a colourless oil. IR νmax (neat)/cm−1: 3345, 2953, 2930, 2896, 2857, 1718, 1630, 1599, 1585, 1476, 1439, 1343, 1265, 1158, 1091, 1010; 1H NMR (400 MHz, CDCl3): δ 7.65 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 8.0 Hz, 2H), 7.01–6.92 (m, 2H), 6.80 (dd, J = 7.6, 1.6 Hz, 1H), 6.25 (s, 1H), 5.89 (s, 1H), 5.21 (s, 2H), 4.58 (t, J = 4.8, 1H), 3.82 (s, 3H), 3.73 (s, 3H), 3.52 (s, 3H), 3.20–3.14 (m, 4H), 2.59 (t, J = 8.0 Hz, 2H), 2.41 (s, 3H), 1.93–1.86 (m, 1H), 1.85–1.68 (m, 3H), 0.90 (s, 9H), 0.04 (s, 3H), −0.03 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 166.17, 150.21, 147.88, 142.84, 142.69, 136.84, 135.40, 129.49, 127.12, 125.09, 123.82, 123.09, 114.60, 95.08, 68.40, 60.63, 56.13, 51.72, 48.07, 44.29, 35.68, 29.32, 27.09, 25.71, 21.40, 18.00, −4.87, −5.20; HRMS (ESIMS) calcd for C32H50N1O8S1Si1 [M + H]+ 636.3021, found 636.3038.
:
1) to give 15 (1.74 g, 2.87 mmol, 62% yield, brsm) as a colourless oil. IR νmax (neat)/cm−1: 3522, 2954, 2930, 2857, 2371, 1599, 1585, 1475, 1340, 1265, 1221, 1157, 1089, 1030, 925; 1H NMR (400 MHz, CDCl3): δ 7.65 (d, J = 8.0 Hz, 2H), 7.27 (d, J = 8.0 Hz, 2H), 7.01–6.94 (m, 2H), 6.80 (dd, J = 7.6, 1.6 Hz, 1H), 6.25 (s, 1H), 5.89 (s, 1H), 5.21 (s, 2H), 4.58 (t, J = 5.2 Hz, 1H), 3.82 (s, 3H), 3.73 (s, 3H), 3.52 (s, 3H), 3.17 (q, J = 4.0 Hz, 4H), 2.61 (t, J = 8.0 Hz, 2H), 2.41 (s, 3H), 1.93–1.86 (m, 1H), 1.85–1.68 (m, 3H), 0.90 (s, 9H), 0.04 (s, 3H), −0.03 (s, 3H); 13C NMR (100 MHz, CDCl3): δ 150.21, 149.52, 147.78, 142.97, 136.78, 135.36, 129.55, 127.07, 123.94, 123.19, 114.64, 111.64, 95.05, 72.72, 62.93, 60.67, 56.16, 48.08, 44.50, 35.22, 29.36, 27.22, 25.69, 21.40, 18.00, −4.86, −5.17; HRMS (ESIMS) calcd for C31H50N1O7S1Si1 [M + H]+ 608.3072, found 608.3082.
:
1) to give 16 (425 mg, 0.947 mmol, 86% yield) as a colourless oil. IR νmax (neat)/cm−1: 3429, 2935, 2874, 1720, 1592, 1473, 1331, 1290, 1155, 1088, 1004; 1H NMR (400 MHz, CDCl3): δ 7.66 (d, J = 8.0 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 6.92 (t, J = 8.0 Hz, 1H), 6.82–6.80 (m, 1H), 6.65 (d, J = 8.0 Hz, 1H), 6.07–5.99 (m, 1H), 5.12 (s, 1H), 5.09 (s, 1H), 4.41–4.40 (m, 1H), 4.21 (dd, J = 32.0, 13.2 Hz, 2H), 3.76 (s, 3H), 3.44–3.36 (m, 1H), 3.24–3.17 (m, 1H), 3.13–3.10 (m, 1H), 3.08–3.00 (m, 1H), 2.62 (t, J = 7.6 Hz, 2H), 2.42 (s, 3H), 1.93–1.72 (m, 4H); 13C NMR (100 MHz, CDCl3): δ 149.28, 149.07, 145.23, 143.40, 136.00, 134.23, 129.73, 127.10, 124.90, 121.25, 114.03, 112.37, 70.44, 64.20, 61.13, 48.92, 45.45, 34.91, 29.39, 26.99, 21.48; HRMS (ESIMS) calcd for C23H31N1O6S1Na1 [M + Na]+ 472.1764, found 472.1768.
17 (75 mg, 0.17 mmol) was dissolved in CH2Cl2 (10 mL), and NaHCO3 (71 mg, 0.85 mmol) was added. After the solution was cooled to 0 °C, DMP (0.36 g, 0.85 mmol) was added in portions, and then the reaction temperature was raised to 25 °C over an hour. The reaction mixture was quenched with sodium thiosulphate solution (10 mL) after 2 h (monitored by TLC), and the mixture was stirred at 25 °C for another 0.5 h, and extracted with CH2Cl2 (3 × 15 mL). The organic layers were combined and washed with water (3 mL) and brine (3 mL), and dried over anhydrous Na2SO4. The solvent was evaporated under reduced pressure and the residue was purified through silica chromatography (n-hexane/EtOAc, 1
:
1) to give 5 (32 mg, 0.072 mmol, 42% yield) as a clear crystal. M.p. 208–210 °C. IR νmax (neat)/cm−1: 3458, 3383, 2948, 2373, 1740, 1703, 1597, 1452, 1338, 1269, 1160, 1090, 1043, 1002; 1H NMR (400 MHz, CDCl3): δ 7.67 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 6.45 (t, J = 8.0 Hz, 1H), 6.36 (br, 1H), 4.81 (br, 1H), 4.12 (d, J = 7.2 Hz, 1H), 3.61 (s, 3H), 3.44–3.43 (m, 1H), 3.30–3.28 (m, 1H), 3.13 (m, 3H), 2.44 (s, 3H), 2.27–2.18 (m, 2H), 2.04–1.97 (m, 2H), 1.96–1.88 (m, 1H), 1.63 (m, 1H); 13C NMR (100 MHz, CDCl3): δ 201.95, 143.70, 134.58, 133.63, 129.75, 128.42, 127.16, 100.83, 73.68, 60.59, 54.48, 48.86, 47.12, 45.69, 23.35, 22.25, 21.42, 14.10; HRMS (ESIMS) calcd for C23H27N1O6S1H1 [M + H]+ 446.1632, found 446.1629.
Footnote |
| † Electronic supplementary information (ESI) available. CCDC 1438512. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c6qo00222f |
| This journal is © the Partner Organisations 2016 |